Development of an Androgen Reporter gene assay (AR-LUX) utilizing a human cell line with an endogenously regulated androgen receptor

Analytical Biochemistry

Volumn 298, Issue 1, 2001, Pages 93-102

  Blankvoort, B M G ^a   De Groene, E M ^c   Van Meeteren Kreikamp, A P ^a   Witkamp, R F ^a   Rodenburg, R J T ^a   Aarts, J M M J G ^b  

^a TNO   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; GENES;

ALL-TRANS RETINOIC ACIDS; ANDROGEN RESPONSE ELEMENTS; DETECTION AND QUANTIFICATIONS; EPIGALLOCATECHIN GALLATE; HIGH THROUGHPUT SCREENING; HUMAN BREAST CANCER CELLS; LUCIFERASE EXPRESSION; TRANSCRIPTIONAL CONTROL;

CELL CULTURE;

ALDOSTERONE; ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; BOLASTERONE; DEXAMETHASONE; EPIGALLOCATECHIN GALLATE; ESTRADIOL; FORSKOLIN; LUCIFERASE; PROGESTERONE; RETINOIC ACID; TRENBOLONE; VITAMIN D;

ARTICLE; ASSAY; CANCER CELL CULTURE; CONTROLLED STUDY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RELIABILITY; REPORTER GENE; TRANSCRIPTION REGULATION; VALIDATION PROCESS;

EID: 0035499955     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1006/abio.2001.5352     Document Type: Article

References (52)

1. The androgen receptor: A mediator of diverse responses
2. Environmental antiandrogens: Developmental effects, molecular mechanisms, and clinical implications
3. Environmental hormone disruptors: Evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites
4. Endocrine disruptors and reproductive development: A weight-of-evidence overview
5. Inhibition of androgen receptor-dependent transcriptional activity by DDT isomers and methoxychlor in HepG2 human hepatoma cells
6. Human exposure to endocrine-active chemicals: Hazard assessment problems
7. Hormonal carcinogenesis
8. Prostate cancer: Molecular biology of early progression to androgen independence
9. Pharmacological profile of RU 58642, a potent systemic antiandrogen for the treatment of androgen-dependent disorders
10. The fungicide procymidone alters sexual differentiation in the male rat by acting as an androgen-receptor antagonist in vivo and in vitro
11. Flutamide inhibits testosterone-induced masculine sexual behavior in male and female rats
12. Rapid and sensitive reporter gene assays for detection of antiandrogenic and estrogenic effects of environmental chemicals
13. Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay
14. Stable transfection of androgen receptor and MMTV-CAT into mammalian cells: Inhibition of cat expression by anti-androgens
15. Examination of selected food additives and organochlorine food contaminants for androgenic activity in vitro
16. A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects
17. The human androgen receptor: Domain structure, genomic organization and regulation of expression
18. Set of optimized luciferase reporter gene plasmids compatible with widely used CAT vectors
19. Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter
20. Estrogen control of progesterone receptor in human breast cancer: Correlation with nuclear processing of estrogen receptor
21. Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide
22. Biological regulation of receptor-hormone complex concentrations in relation to dose-response assessments for endocrine-active compounds
23. Structural evidence for ligand specificity in the binding domain of the human androgen receptor: Implications for pathogenic gene mutations
24. A RAL compound as an anabolic in cattle
25. Evaluation of a Tier I screening battery for detecting endocrine-active compounds (EACs) using the positive controls testosterone, coumestrol, progesterone, and RU486
26. Drospirenone: A novel progestogen with antimineralocorticoid and antiandrogenic activity
27. Estrogenic and progestagenic activities of physiologic and synthetic androgens, as measured by in vitro bioassays
28. Selective activation of the probasin androgen-responsive region by steroid hormones
29. Activation of retinoic acid receptor-α is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells
30. Vitamin D receptors in breast cancer cells
31. Regulation of androgen receptor mRNA and protein level by steroid hormones in human mammary cancer cells
32. Regulation of androgen receptor gene expression by steroids and retinoic acid in human breast-cancer cells
33. Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells
34. Androgen receptor and vitamin D receptor in human ovarian cancer: Growth stimulation and inhibition by ligands
35. The androgen-specific probasin response element 2 interacts differentially with androgen and glucocorticoid receptors
36. Differential transactivation by the androgen receptor in prostate cancer cells
37. Androgen receptor antagonists (antiandrogens): Structure-activity relationships
38. Distinguishing androgen receptor agonists and antagonists: Distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone
39. Steroid receptor induction of gene transcription: A two-step model
40. Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells
41. Differential induction of the androgen receptor transcriptional activity by selective androgen receptor coactivators
42. Environmental xenobiotics and the antihormones cyproterone acetate and spironolactone use the nuclear hormone pregnenolone X receptor to activate the CYP3A23 hormone response element
43. C19 steroids estrogenic activity in human breast cancer cell lines: Importance of dehydroepiandrosterone sulfate at physiological plasma concentration
44. Induction of androgen receptor by 1alpha,25-dihydroxyvitamin D3 and 9-cis retinoic acid in LNCaP human prostate cancer cells
45. Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate
46. Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gamma
47. Androgen receptor phosphorylation
48. CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1
49. CREB-binding protein in androgen receptor-mediated signaling
50. Inducible binding of cyclic adenosine 3′,5′-monophosphate (cAMP)-responsive element binding protein (CREB) to a cAMP-responsive promoter in vivo
51. Forskolin-induced dephosphorylation of the androgen receptor impairs ligand binding